Guardion Health Sciences (NASDAQ:GHSI) Shares Down 59.7%
Guardion Health Sciences Inc (NASDAQ:GHSI) dropped 59.7% during trading on Tuesday . The stock traded as low as $0.20 and last traded at $0.24, approximately 13,808,651 shares traded hands during trading. An increase of 1,978% from the average daily volume of 664,603 shares. The stock had previously closed at $0.60.
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.15 and a current ratio of 0.35. The business’s fifty day moving average price is $1.18.
Guardion Health Sciences (NASDAQ:GHSI) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.14) EPS for the quarter. The business had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 687.43% and a negative return on equity of 212.45%.
Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Further Reading: What is meant by buying and selling pressure?
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.